We seek an enthusiastic Associate Medical Director/Medical Director with a high degree of scientific acumen to help develop clinical plans for CRISPR?s CAR-T programs and is excited by the unique opportunity to bring cutting-edge gene therapies to market.
In this role, the incumbent will report to the VP Clinical Development and help develop CRISPR?s CAR-T programs created for the treatment of various malignant hematologic diseases. The successful candidate will work across different functional teams, support clinical development function and be responsible for tactical implementation of the early clinical studies for our lead programs. This will include providing direct medical oversight for proof of concept and pivotal clinical trials, and clinician input into all aspects of discovery and preclinical development, from target selection to preclinical and regulatory strategy and tactics. In this high visibility position, the candidate will be interfacing with both internal and external stakeholders including KOLs and Principal Investigators.
Contribute to the development of robust product development plans for IO program,
Develop protocols and oversee clinical trials as a medical monitor
Understand (and eventually develop into local expert for) the underlying scientific principles of the disease indications and pipeline molecules being studied
Collaborate within clinical development partners and across functions to ensure program success
Contribute to the development of regulatory strategy and act as the medical expert in meetings with regulatory authorities
Identify and establish relationships with leading KOL?s and principal investigators, including organizing and running KOL meetings, as needed
Organize and present at relevant clinical advisory boards and medical/scientific meetings
Ensure and support effective leadership, management and governance, and seamless collaboration across all areas of Research and Development
Serve as the Sponsor?s medical representative to external collaborators
Travel, as needed, nationally and internationally
A medical degree (MD), and 1-2 years Pharmaceutical/Biotech industry experience, including time managing clinical trials, or a minimum of 5 years in a related, research/academic environment. Background in oncology, hematology, stem cell transplantation, or cell therapies is preferred.
Strong scientific background with experience in reviewing & interpreting scientific and study data is required
Medical monitor experience in clinical development, or clinical translational medicine related areas
Working knowledge of biostatistics, data management, clinical operations and scientific and technical processes desirable
Experience in building and maintaining effective relationships with external KOL?s, advisory boards and other key external therapeutic area influencers desirable
Team player who works collaboratively in a team matrix environment
Ability to work independently to resolve challenges and conflicts
Excellent written and oral communication skills
Integrity, honesty and highest ethical standards and a sense of personal accountability
Quickly adapt and provide innovative solutions to challenges as they present themselves
Ability to travel on average 20% of the time (range 0-30% each month)
Scientifically rigorous, highly organized, and with significant attention to detail
CRISPR Therapeutics, Inc. is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.
To view our Privacy Statement, please click the following link: http://www.crisprtx.com/about-us/privacy-policy
USA Cares exists to help bear the burdens of service by providing post-9/11 military families with financial and advocacy support in their time of need.
USA Cares is a national 501(c)(3) non-profit, charitable organization based in Kentucky and registered with the IRS.